Common Equity: The sum of all common equity items.
TELA Bio, Inc. (TELA) had Common Equity of $6.31M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$80.28M |
|
$-38.83M |
|
$25.55M |
|
$54.72M |
|
$114.03M |
|
$-33.76M |
|
$-4.85M |
|
$-38.60M |
|
$-38.60M |
|
$-38.83M |
|
$-38.83M |
|
$-38.83M |
|
$-38.83M |
|
$-33.76M |
|
$-32.74M |
|
46.95M |
|
46.95M |
|
$-0.83 |
|
$-0.83 |
|
| Balance Sheet Financials | |
$75.58M |
|
$2.23M |
|
$5.84M |
|
$81.42M |
|
$17.98M |
|
$55.65M |
|
$57.13M |
|
$75.11M |
|
|
Common Equity |
$6.31M |
$4.95M |
|
$6.31M |
|
44.54M |
|
| Cash Flow Statement Financials | |
$-28.22M |
|
$0.85M |
|
$25.75M |
|
$52.94M |
|
$51.09M |
|
$-1.84M |
|
$3.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.20 |
|
-- |
|
-- |
|
0.90 |
|
8.82 |
|
68.17% |
|
-42.05% |
|
-42.05% |
|
-40.79% |
|
-48.09% |
|
-48.37% |
|
$-28.67M |
|
-- |
|
-- |
|
-- |
|
0.99 |
|
2.32 |
|
7.76 |
|
47.05 |
|
-615.09% |
|
-783.83% |
|
-47.69% |
|
-62.66% |
|
$0.14 |
|
$-0.61 |
|
$-0.60 |
|